Joliet Diabetes/Endocrinology Associates Inc Joliet, IL - 60435

Joliet Diabetes/Endocrinology Associates Inc is categorized under Endocrinologists in Joliet, IL and active since 2010.

Joliet Diabetes/Endocrinology Associates Inc was established in 2010, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Endocrinologists business, which does work in the B2C market, and is classified as a Endocrinologists, under code number 621111 by the NAICS.

If you are seeking more information, feel free to contact Bhavani Sivarajan at the company’s single location by writing to 1715 Glenwood Avenue, Joliet, Illinois IL 60435 or by phoning (815) 744-1089. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Joliet Diabetes/Endocrinology Associates Inc
Contact Person: Bhavani Sivarajan
Address: 1715 Glenwood Avenue, Joliet, Illinois 60435
Phone Number: (815) 744-1089
Annual Revenue (USD): $100.000 to $499.999
Founded: 2010
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Endocrinologists
SIC Code: 8011
NAICS Code: 621111
Share This Business:

Joliet Diabetes/Endocrinology Associates Inc was started in 2010 to provide professional Endocrinologists under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Bhavani Sivarajan for inquiries that concern Joliet Diabetes/Endocrinology Associates Inc by calling the company number (815) 744-1089, as your correspondence is most welcome. Additionally, the physical location of the single location of Joliet Diabetes/Endocrinology Associates Inc can be found at the coordinates 41.530071,-88.123514 as well as the street address 1715 Glenwood Avenue in Joliet, Illinois 60435.

For its online presence, you may visit Joliet Diabetes/Endocrinology Associates Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.